Physician profile
Bassem Mazloum
NPI 1154374742
$769.19
in general payments reported to CMS, 2019-2025
15 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $30.43 · 2021: $17.61 · 2022: $138 · 2023: $97.11 · 2024: $52.34 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $171.02 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.49 | 2022-2025 | Xifaxan |
| Abbvie INC. | $110.33 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.98 | 2019 | |
| Janssen Biotech, INC. | $49.55 | 2021-2025 | Tremfya |
| Alfasigma USA, INC. | $30.43 | 2020 | |
| Redhill Biopharma INC. | $30.25 | 2022 | |
| Phathom Pharmaceuticals, INC. | $27.88 | 2025 | Voquezna |
| Angiodynamics, INC. | $23.52 | 2023 | Auryon Laser System 100-120 Vac |
| Biocon Biologics INC | $21.47 | 2025 | Yesintek |
| Nestle Healthcare Nutrition INC. | $21.34 | 2022 | |
| Pfizer INC. | $18.88 | 2023 | |
| Celgene Corporation | $18.19 | 2023 | |
| Allergan, INC. | $15.39 | 2019 | |
| Ardelyx, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassem Mazloum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.